Harvard Business Review

MARCH 28, 2012

This ongoing struggle raises an issue that is endemic in such acquisitions: In search of innovation, big companies often buy other companies whose most innovative days are almost at an end. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now.

Innovation 13

Innovation Company Biotechnology CFO 13

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In effect, the VCs at Nadathur Holdings serve as the executive team for a miniature healthcare innovation ecosystem.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

OCTOBER 26, 2011

In the last year, however, early-stage investments in clean energy production technologies have fallen substantially (see the table at the end of this piece for more detail). Despite these gloomy headlines, three developments in the sector give us hope that the revolution in clean energy production is far from dead: 1.

Energy 10

Energy Finance IPO Biotechnology 10

Harvard Business Review

MARCH 1, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. Fortunes have been made from implants, surgical instruments, and artificial products. In all of these settings, physicians and patients are happy.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

OCTOBER 1, 2014

The implicit axiom here is that robust companies that have sustained and grown over the longer term are somehow less innovative. And Alibaba is a 16 year-old company, and no one is claiming it is sluggish or un-innovative.)

Entrepreneur 11

Entrepreneur Biotechnology Real Estate Innovation 11

Harvard Business Review

MARCH 1, 2012

It's a private, independent company in the Chicago area that handles biopharma production for a number of partners. Hospira began life when Abbott Laboratories spun off its production division, and it is now the world leader in the production of injectable pharmaceuticals. For example, in biotechnology, a field in which the U.S.

Contract Manufacturing 8

Contract Manufacturing Offshoring Supply Chain Biotechnology 8

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Finding ideas is never the problem — initially. Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

MARCH 8, 2013

Many of the revolutionary technologies that make the iPhone and other products and services "smart" were funded by the U.S. government, which through DARPA and other initiatives stands out worldwide for its astoundingly positive track record in funding true innovation. Over the years. taxpayers have been very good to Apple. government.

Venture Capitalist 8

Venture Capitalist Biotechnology Fashion Innovation 8

Harvard Business Review

JUNE 16, 2016

The private sector spends three times that , mostly on translational research intended to transform basic discoveries into new products. There is a wide chasm that separates an initial discovery and a viable product idea. Innovating the Innovation Process. Yet the Valley of Death still remains. Killing Ideas Faster.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

JUNE 4, 2018

’s “once unchallenged preeminence in commerce, industry, science, and technological innovation is being overtaken by competitors throughout the world.” .” This groundbreaking report, commissioned by President Ronald Reagan, concluded that the U.S.’s ” Unfortunately, this goal hasn’t been met.

Education 8

Education Company Biotechnology Human Capital 8

Harvard Business Review

OCTOBER 16, 2013

If we want to have a strong economy, we need to make sure we’re tilting the playing field in favor of entrepreneurs that are trying to challenge the status quo, innovate, create new products and services, disrupt existing industry, usher in a new way. They are fueling innovation and growth. A restaurant might start.

Venture Capitalist 9

Venture Capitalist Company Biotechnology Transportation 9

Harvard Business Review

MARCH 13, 2012

This systematic experimentation is similar to the experimentation that happens in labs to test out scientific hypotheses or in corporations to test out a product before it is sold widely. Is it possible that local funding could help bolster tourism in Florida, biotechnology in California, publishing in New York, and agriculture in Iowa?

Biotechnology 9

Biotechnology Real Estate Tourism Banking 9

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. The positions are there for the taking. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

The Horizons Tracker

DECEMBER 30, 2019

The paper explores the progress of startups in the US and Israel, and shows that startups that move to America tend to raise more money, get acquired more often, and introduce more new products than their peers that remain in Israel. They raised more money and were acquired at higher valuations; however, they did not innovate more.

Biotechnology 65

Biotechnology Human Capital Travel Entrepreneur 65

Harvard Business Review

APRIL 19, 2016

has been an innovation superpower. In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. As Bush wrote in 1945: “New products and new processes do not appear full-grown. vincent tsui FOR HBR.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

FEBRUARY 3, 2015

Make you more innovative. Uzzi and another colleague, Jarrett Spiro, also discovered that this pattern held across sectors as disparate as the Broadway mu­sical industry and biotechnology. Jones, and Brian Uzzi, “The Increasing Dominance of Teams in Production of Knowledge,” Science 316, no. The list goes on.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

MARCH 5, 2012

A major reason for the decline in manufacturing employment in recent decades is the huge increases in the productivity of American factories. With those productivity gains likely to continue (a good thing), it is hard to imagine how manufacturing could ever return to its glory days, when it employed about a quarter of the U.S.

Health Care 9

Health Care Biotechnology Industry Policies 9

Harvard Business Review

MAY 28, 2013

Not innovation, risk management, technology, debt, or the regulatory environment. chemicals, metals and mining, paper and forest products), made out worst, scoring poorly on "firing" and "leveraging diversity," and not much better on "assessing talent" and "developing talent.". chemicals, metals & mining, paper & forest products).

Talent Management 8

Talent Management Company Telecommunications Management 8

Harvard Business Review

MARCH 30, 2017

Received wisdom is that the more diverse the teams in terms of age, ethnicity, and gender, the more creative and productive they are likely to be. We worked with a startup biotechnology company. The exercise requires the group to formulate and execute a strategy to achieve a specified outcome, against the clock.

Diversity 8

Diversity Team Biotechnology Execution 8

Harvard Business Review

SEPTEMBER 11, 2014

That’s because there are two primary types of uncertainty — demand uncertainty (will customers buy your product?) If you’re in the upper right quadrant — or in the top 10 most uncertain industries as shown in the Table — you require greater innovation management skills than industries in the other quadrants or in the bottom 10.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

JUNE 12, 2012

trillion in government support for seven "strategic emerging industries," including alternative energy, biotechnology, next-gen IT, high-end manufacturing equipment, and advanced materials. The United States is home to some of the key pioneers of Technik whose innovations help society adapt to the future. It pledges $1.5

First-mover Advantage 9

First-mover Advantage GDP Technology Biotechnology 9

Harvard Business Review

NOVEMBER 9, 2016

To cope with the cyclical variations of copper prices, the industry made an innovative leap into the health care sector, a move that represents a clear departure from the commodity trap. New Zealand is the world’s largest exporter of dairy products. They supported world-class research and innovation locally.

Cooper 14

Cooper Long-term Industry Health Care 14